Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
STSSW
Upturn stock ratingUpturn stock rating

Sharps Technology Inc. Warrant (STSSW)

Upturn stock ratingUpturn stock rating
$0.05
Last Close (24-hour delay)
Profit since last BUY-37.5%
upturn advisory
WEAK BUY
BUY since 19 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/10/2025: STSSW (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -80.47%
Avg. Invested days 20
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 10/10/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 1.92
52 Weeks Range 0.01 - 0.14
Updated Date 05/24/2025
52 Weeks Range 0.01 - 0.14
Updated Date 05/24/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.96

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -42.67%
Return on Equity (TTM) -75.14%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 1017855
Shares Outstanding -
Shares Floating 1017855
Percent Insiders -
Percent Institutions -

ai summary icon Upturn AI SWOT

Sharps Technology Inc. Warrant

stock logo

Company Overview

overview logo History and Background

Sharps Technology, Inc. focuses on developing and manufacturing innovative medical devices, including prefilled syringes and other safety injection products. Founded to address the need for safer injection practices, the company aims to reduce needlestick injuries and improve patient outcomes. Information about the warrant specifically is limited as it's a derivative of the stock.

business area logo Core Business Areas

  • Medical Device Manufacturing: Sharps Technology develops and manufactures disposable medical devices, including prefilled syringes, syringes with safety features, and custom injection devices.

leadership logo Leadership and Structure

Information on the leadership team specific to the warrants is limited, but it's related to the overall Sharps Technology Inc. leadership.

Top Products and Market Share

overview logo Key Offerings

  • Prefilled Syringes: Sharps Technology focuses on prefilled syringes with safety features to minimize needlestick injuries. Market share data for the warrant itself isn't applicable as it's a derivative financial instrument. Competitors: Becton Dickinson (BDX), Medtronic (MDT), Gerresheimer (GRRMF).

Market Dynamics

industry overview logo Industry Overview

The medical device industry is driven by technological advancements, regulatory requirements, and the increasing demand for safer and more efficient healthcare solutions. Safety syringes are gaining traction due to concerns about healthcare worker safety and disease transmission.

Positioning

Sharps Technology aims to differentiate itself through innovative safety features and specialized prefilled syringe solutions. Their position is in a niche market requiring safety and customized solutions.

Total Addressable Market (TAM)

The global prefilled syringes market is expected to reach billions of dollars. Sharps Technology is positioned to capture a share of this market through its specialized offerings.

Upturn SWOT Analysis

Strengths

  • Innovative safety features
  • Specialized prefilled syringe solutions
  • Strong focus on needlestick injury prevention

Weaknesses

  • Relatively small market presence compared to larger competitors
  • Dependence on specific niche markets

Opportunities

  • Increasing demand for safety syringes
  • Expansion into new geographic markets
  • Partnerships with pharmaceutical companies

Threats

  • Competition from larger, established medical device manufacturers
  • Regulatory changes affecting medical device approvals
  • Pricing pressures from healthcare providers

Competitors and Market Share

competitor logo Key Competitors

  • BDX
  • MDT
  • GRRMF

Competitive Landscape

Sharps Technology competes with larger medical device manufacturers. Its competitive advantage lies in its focus on safety and specialized solutions, but it faces challenges in terms of market reach and resources.

Growth Trajectory and Initiatives

Historical Growth: Historical growth is dependent on the overall performance of Sharps Technology Inc.

Future Projections: Future projections depend on factors such as market adoption of safety syringes and successful commercialization of new products.

Recent Initiatives: Recent initiatives might include partnerships, new product development, and expansion into new markets.

Summary

Sharps Technology Inc. warrants' value is tied directly to the underlying SHSP stock. The company focuses on innovative safety features in prefilled syringes and custom injection devices. The company is positioned within a growing niche in the medical device market, but faces stiff competition from larger players. Their growth depends on market adoption and successful partnerships.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (SHSP), Industry reports, Market research

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on thorough research and consultation with a financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Sharps Technology Inc. Warrant

Exchange NASDAQ
Headquaters Melville, NY, United States
IPO Launch date 2022-04-14
CEO & Director Mr. Robert M. Hayes
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 55
Full time employees 55

Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.